Evidence map›Paper›PMID 28879687›Full record

ArticleAngewandte Chemie (International ed. in English)2017

Recombinant Synthesis of Hybrid Lipid-Peptide Polymer Fusions that Self-Assemble and Encapsulate Hydrophobic Drugs.

Kelli M Luginbuhl, Davoud Mozhdehi, Michael Dzuricky, Parisa Yousefpour, Fred C Huang, Nicholas R Mayne, Kristen L Buehne, Ashutosh Chilkoti

Open access · greenAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 67 citations in OpenAlex.

  1. The Polymers of Life: Exploring Cellular Function Through Polymer Concepts.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Applications of synthetic biology in medical and pharmaceutical fields.Signal transduction and targeted therapy · 2023
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Kelli M LuginbuhlDepartment of Biomedical Engineering, Duke University, 1427 FCIEMAS, Box 90281, USA.ORCID 0000-0002-6713-0331
Davoud MozhdehiDepartment of Biomedical Engineering, Duke University, 1427 FCIEMAS, Box 90281, USA.
Michael DzurickyDepartment of Biomedical Engineering, Duke University, 1427 FCIEMAS, Box 90281, USA.
Parisa YousefpourDepartment of Biomedical Engineering, Duke University, 1427 FCIEMAS, Box 90281, USA.
Fred C HuangDepartment of Biomedical Engineering, Duke University, 1427 FCIEMAS, Box 90281, USA.
Nicholas R MayneDepartment of Biomedical Engineering, Duke University, 1427 FCIEMAS, Box 90281, USA.
Kristen L BuehneDepartment of Biomedical Engineering, Duke University, 1427 FCIEMAS, Box 90281, USA.
Ashutosh ChilkotiDepartment of Biomedical Engineering, Duke University, 1427 FCIEMAS, Box 90281, USA.ORCID 0000-0002-1569-2228
Duke University · US

Funding

ELASTIN FUSION PROTEINSR01GM061232 · NIGMS · DUKE UNIVERSITY · PI CHILKOTI, ASHUTOSH · 2000 to 2017
$4.6M
Thermally Targeted Drug Delivery by Elastin BiopolymersR01EB000188 · NIBIB · DUKE UNIVERSITY · PI CHILKOTI, ASHUTOSH · 2002 to 2015
$3.9M
NIBIB NIH HHS R01 EB000188NIGMS NIH HHS R01 GM061232
6 · The paper itself

Abstract

Inspired by biohybrid molecules that are synthesized in Nature through post-translational modification (PTM), we have exploited a eukaryotic PTM to recombinantly synthesize lipid-polypeptide hybrid materials. By co-expressing yeast N-myristoyltransferase with an elastin-like polypeptide (ELP) fused to a short recognition sequence in E. coli, we show robust and high-yield modification of the ELP with myristic acid. The ELP's reversible phase behavior is retained upon myristoylation and can be tuned to span a 30-60 °C. Myristoylated ELPs provide a versatile platform for genetically pre-programming self-assembly into micelles of varied size and shape. Their lipid cores can be loaded with hydrophobic small molecules by passive diffusion. Encapsulated doxorubicin and paclitaxel exhibit cytotoxic effects on 4T1 and PC3-luc cells, respectively, with potencies similar to chemically conjugated counterparts, and longer plasma circulation than free drug upon intravenous injection in mice.

Indexed as

AcyltransferasesAnimalsAntineoplastic AgentsChromatography, High Pressure LiquidDoxorubicinElectrophoresis, Polyacrylamide GelEscherichia coliHot TemperatureHydrophobic and Hydrophilic InteractionsLipidsMicePaclitaxelPeptidesPharmaceutical PreparationsPolymersProof of Concept StudyAcyltransferasesAntineoplastic AgentsDoxorubicinglycylpeptide N-tetradecanoyltransferaseLipidsPaclitaxelPeptidesPharmaceutical PreparationsPolymersdrug deliverylipidationmyristic acidpost-translational modificationself-assembly

Identifiers

PMID28879687
PMCPMC5909378
OpenAlexW2752537178

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.